Congress is Expected to Bring PBM Transparency Legislation

September 6, 2023

Any federal bill regulating the pharmacy benefit management (PBM) industry that makes it to President Joe Biden’s desk will likely be focused on transparency issues and not on providing broad changes to the industry. Robyn Crosson, JD, Vice President, Government Relations at Navitus Health Solutions was one of several speakers to share her thoughts at the Pharmacy Benefit Management Institute’s annual conference in Orlando.

MORE ABOUT Robyn Crosson

Robyn Crosson is the Vice President of Government Relations at Navitus, where she provides strategic direction on government relations thought-leadership initiatives. She oversees building external relationships with state and federal governments, lobbyists and stakeholders. Her team focuses on legislation and proposed rules/regulations concerning the pharmaceutical, PBM and health care industries.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

CLARITY FOR ACTION

Gain Clarity: Navitus 10th Annual Drug Trend Report Ready to Download

Our 2025 report provides transparent, data-driven insight to help plans, plan sponsors and consultants navigate an increasingly complex prescription drug landscape.

Related blogs

Navigating Healthcare and Improving Outcomes

Get to Know the PBM Pass-through Model

Get to Know the PBM Pass-through Model

In the world of pharmacy benefit management (PBM), there are multiple models a company can follow, including the pass-through, hybrid and traditional models. While all PBMs negotiate discounts and rebates with manufacturers on behalf of their clients,…

previous arrow
next arrow